Figures
Abstract
Short-chain α-neurotoxins (SNTXs) are the principal neurotoxic components in several Asiatic cobras, including Naja atra, Naja philippinensis, and Naja samarensis. Although structurally conserved, SNTXs exhibit marked antigenic variation that can limit the effectiveness of regional antivenoms used for snakebite envenoming in Asia. Here, we evaluated the immunoreactivity of the Philippine Cobra Antivenom (PCAV) and three regional products—Naja kaouthia Monovalent Antivenom (NkMAV), Neuro Bivalent Antivenom (NBAV), and Indonesian SABU—against a panel of cobra venoms and purified α-neurotoxins. PCAV bound strongly to homologous N. philippinensis SNTX but showed significantly lower cross-reactivity with SNTXs from Naja kaouthia, Naja sputatrix, and N. atra, and minimal recognition of marine elapid SNTXs and long-chain α-neurotoxins (LNTXs) of Monocled Cobra as well as King Cobra. Conversely, NkMAV and NBAV recognized mainland Asian SNTXs more broadly but reacted poorly with the Philippine cobra toxin. These differences were statistically significant in multiple comparisons versus the homologous venom control. Hierarchical clustering of normalized immunoreactivity delineated two major SNTX antigenic subtypes corresponding to Philippine versus continental Asian lineages. Peptide sequence analysis unmasked two distinct loop-II motifs (28WWS–TII37 and 28RWR–YRT37) associated with these divergent immunotypes. Phylogenetic reconstruction suggests that the Philippine cobras retain an ancestral-like SNTX motif, while Sundaic and East Asian cobras have diversified to employ another major SNTX form. Epitope prediction further revealed differences in surface exposure and accessibility, which helps explain the limited cross-neutralization among antivenoms. These findings demonstrate a clear antigenic dichotomy among Asian cobra SNTXs, which underlies species-specific antivenom effectiveness and highlights the need to incorporate representative SNTX variants into immunogen formulations to improve regional antivenom coverage.
Author summary
Snakebite envenoming by Asiatic cobras is a major public health problem, where paralysis is primarily caused by short-chain α-neurotoxins (SNTXs). Antivenoms are the only specific treatment, but their effectiveness often varies across regions. In this study, we examined how well different Asian antivenoms recognize SNTXs from several cobra species. We found that antivenoms tend to work best against the species they were raised against, but show reduced effectiveness against toxins from other regions. Notably, the Philippine Cobra Antivenom strongly recognized toxins from the Philippine cobra but poorly detected those from mainland Asian cobras, while mainland antivenoms showed the opposite pattern. By analyzing toxin sequences, we identified two distinct molecular signatures in a critical toxin region (loop II), which define separate antigenic groups corresponding to Philippine and continental Asian cobras. These differences influence how accessible the toxin surfaces are to antibodies, helping to explain why cross-neutralization across different species and regions is limited. Together, our findings reveal a clear antigenic divide among cobra neurotoxins in Asia, which directly impacts antivenom performance. This highlights the importance of incorporating diverse toxin variants when producing antivenom, so that treaments can provide broader and more effective protection across regions.
Citation: Tan CH, Palasuberniam P, Pernee LL, Tan KY (2026) Antigenic divergence of cobra short-chain α-neurotoxins: Implications for regional antivenom effectiveness in Southeast Asia. PLoS Negl Trop Dis 20(5): e0013859. https://doi.org/10.1371/journal.pntd.0013859
Editor: Wuelton Monteiro, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado: Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado, BRAZIL
Received: December 13, 2025; Accepted: May 4, 2026; Published: May 14, 2026
Copyright: © 2026 Tan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: The authors receive funding support from the National Science and Technology Council (NSTC) of Taiwan (114-2311-B-007-005 to CHT), funding for international collaboration from the National Tsing Hua University (114QI010E1 to CHT), and the special research grant of Universiti Malaya, Malaysia (BKS003-2020 to CHT and KYT).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Snakebite envenoming is a WHO-listed priority neglected tropical disease that disproportionately affects rural and low-income communities across Asia [1]. As a One Health challenge spanning human health, biodiversity, and regional healthcare inequities, snakebite envenoming requires improved antivenom coverage informed by a deeper understanding of venom variation among medically important snakes [2,3]. Cobra venoms, in particular, exhibit striking interspecific and geographical diversity in toxin composition, which directly influences clinical severity and treatment outcomes [3]. Within these venoms, three-fingered protein toxins represent the dominant neurotoxic components responsible for rapid paralysis in neurotoxic snakebites. Proteins with the three-finger fold are widely distributed among metazoans and play critical physiological roles. For instance, the GPI-anchored Lynx1 protein modulates cholinergic transmission by fine-tuning nicotinic acetylcholine receptors (nAChRs) in mammals, influencing learning, memory, and neural plasticity. Similarly, secretory three-finger proteins (TFPs) such as SLURP-1 and SLURP-2 are involved in cell proliferation, immune responses, and tissue repair [4–6]. In some advanced snakes, these ancestral physiological proteins were co-opted for neofunctionalization, as the inherent plasticity of the three-finger motif allowed it to be exploited and repurposed for diverse toxic effects, including cytotoxicity to neurotoxicity [7,8]. This evolutionary adaptation has given rise to a new class of TFPs known as three-finger toxins (3FTXs), which are predominantly found in the Elapidae family, including cobras, kraits, king cobras, coral snakes, mambas, and sea snakes [3–9,11].
Within the 3FTX family, alpha-neurotoxins are among the most well-studied members. These toxins act as high-affinity competitive blockers of postsynaptic muscle-type nAChRs [12]. The alpha-neurotoxins are broadly classified into two subfamilies based on peptide length and the number of intramolecular disulfide bonds: (1) short-chain α-neurotoxins (SNTX), which have 60–62 residues and four disulfide bridges; and (2) long-chain α-neurotoxins (LNTX), which consist of 66–75 residues and five disulfide bridges. In cobras (Naja spp.), alpha-neurotoxins are the principal 3FTXs responsible for neurotoxic envenoming, resulting in systemic paralysis and potentially fatal respiratory failure. The abundance of these toxins in venom correlates positively with venom lethality, as measured by intravenous median lethal doses (LD50), where higher levels of alpha-neurotoxin protein correspond to greater venom potency [12].
The distribution of alpha-neurotoxins in cobra venom varies across species and geographical regions. Recent findings from cobra venomics and phylogeographical studies reveal a phenotypic dichotomy in venom composition, characterized by a transition in alpha-neurotoxin subtype that accompanies the biogeographical distribution of cobra species, honed by evolutionary pressures to fulfill specific ecological roles. In Naja naja (Indian cobra), LNTX predominates, while in Asiatic cobras that have dispersed eastward, a more evolutionarily derived form—without loss of lethality—has largely replaced LNTX. For example, venoms of N. atra (Taiwan), N. kaouthia (Vietnam), N. philippinensis, and N. samarensis (Philippines) contain predominantly SNTX, with LNTX virtually absent [12–15]. Despite their structural similarities, SNTX and LNTX exhibit distinct pharmacological profiles at nicotinic acetylcholine receptor (nAChR) subtypes. LNTX is often considered more medically relevant in snakebite envenomation due to its stronger binding affinity toward human nAChRs compared to SNTX [16,17]. This increased affinity is likely due to the additional disulfide bond in loop II of LNTX, which SNTX lacks. Whether this translates to reduced fatality of SNTX in human envenomation is inconclusive, and the toxicity of SNTX should be reckoned with for its high potency and rapid action. Of note, both SNTX and LNTX have comparable lethality in rodent models (LD50 values typically range between 0.1 and 0.2 µg/g, intravenously), and the lethality of venom during envenomation depends on the abundance of the dominant alpha-neurotoxin form. For instance, Philippine cobras cause prominent neurotoxicity with rapid onset in humans, despite SNTX being the only alpha-neurotoxin form present in their venom (Watt et al., 1988).
From the treatment perspective, clinically effective antivenoms must be able to immunorecognize and neutralize the dominant neurotoxin in a venom. However, antivenoms often exhibit lower neutralization activity against SNTX than LNTX, possibly due to the limited antigenicity of SNTX proteins [18–20]. SNTX and LNTX share common epitopes within their respective subgroups, enabling cross-reactivity and cross-neutralization by antivenoms raised against different cobra species in Southeast Asia. For instance, N. kaouthia Monovalent Antivenom (NkMAV) produced in Thailand can cross-neutralize the venoms of N. sumatrana (Equatorial Spitting Cobra, Malaysia) and N. sputatrix (Javan Spitting Cobra) [19,21]. However, this is not the case for N. philippinensis, as its venom toxicity can only be effectively neutralized by species-specific Philippine Cobra Antivenom (PCAV) [22]. In comparison, the antivenom raised against N. atra (Neuro Bivalent Antivenom, Taiwan) shows limited effectiveness against N. philippinensis venom. This is unexpected, as proteomic analyses indicate that both species, representing the most eastern-dispersed cobras, predominantly express α-neurotoxins comprising SNTXs, albeit in differing abundances [12,14,23]. These observations raise a broader question of public health importance: Do antigenically distinct “immunoforms” of SNTX exist across Asian cobras, and could this divergence undermine the regional effectiveness of antivenoms used to treat neurotoxic envenoming? Understanding antigenic divergence is directly relevant to snakebite envenoming, a WHO-listed priority neglected tropical disease disproportionately affecting rural communities in Southeast Asia. Regional antivenoms are often relied upon across species and geographical boundaries; however, antigenic incompatibilities may limit cross-neutralization and contribute to treatment failures. While venom composition and sequence variation in cobra toxins have been studied extensively, the degree to which homologous α-neurotoxins differ immunologically remains unclear, particularly for SNTXs, which dominate in Southeast and East Asian cobras.
This study therefore evaluates the immunoreactivity of multiple regional antivenoms toward a panel of elapid venoms and purified α-neurotoxins. We focused on identifying patterns of SNTX antigenicity across species, determining whether distinct immunotypes exist, and characterizing sequence motifs that may underpin divergent antibody recognition. By integrating immunoprofiling with phylogenetic and sequence analyses, we aim to clarify how antigenic divergence among cobra SNTXs shapes antivenom cross-reactivity. These insights may guide the future formulation of antivenoms with broader regional utility and improved therapeutic coverage for neurotoxic snakebite envenomation.
2. Materials and methods
2.1 Venoms and antivenoms
Venoms of Naja philippinensis (Philippines), Naja sputatrix (Indonesia), Naja naja (Pakistan), and Naja kaouthia (Thailand) were supplied by Latoxan (Valence, France). Venoms of Naja sumatrana, Ophiophagus bungarus (formerly Ophiophagus hannah), Hydrophis curtus, and Hydrophis schistosus were collected by author (CHT). Naja atra venom (Taiwan) was provided by Professor Inn-Ho Tsai from Academia Sinica, Taiwan, while Laticauda colubrina venom was from Venom Supplies, Australia. Calloselasma rhodostoma venom was provided by the Queen Saovabha Memorial Institute (Bangkok, Thailand). All venom samples were stored in lyophilized form at -20 °C until use.
The alpha-neurotoxins used in this study were previously isolated and characterized in earlier proteomic investigations conducted by the same laboratory, with relevant details summarized in S1 Table. In these studies, toxins were purified by reverse-phase high-performance liquid chromatography (RP-HPLC, Shimadzu LC-20A, Japan) on a C18 column using acetonitrile gradients in 0.1% TFA, and protein purity was verified by analytical re-chromatography and electrospray mass spectrometry, confirming the dominant molecular species corresponding to the annotated database entries. The same well-characterized toxin preparations were utilized in the present immunoreactivity assays. These include SNTXs from N. philippinensis [12], N. sputatrix [19], N. kaouthia [15], N. atra [24], H. curtus [25], H. schistosus [10], and L. colubrina [26]. LNTXs were also isolated from venoms of N. kaouthia [15], and O. bungarus [27], respectively, for immunoreactivity study.
Philippine Cobra Antivenom (PCAV; Lot# 201804) used in the immunoreactivity is a monovalent antivenom raised against N. philippinensis and is produced by the Research Institute for Tropical Medicine in the Philippines. N. kaouthia Monovalent Antivenom (NkMAV; batch no.: NK00116) is a monospecific antivenom raised against Thai N. kaouthia venom, produced by the Queen Saovabha Memorial Institute (QSMI), Bangkok, Thailand. Neuro Bivalent Antivenom (NBAV; batch no.: 61-06-0002) is a bivalent antivenom raised against Taiwanese N. atra and Bungarus multicintus, manufactured by Taiwan Center for Disease Control, Taipei, Taiwan. Serum Anti Bisa Ular (SABU; batch no.: 4701516) is a polyvalent antivenom raised against N. sputatrix (Javan Spitting Cobra), Bungarus fasciatus (Banded Krait), and C. rhodostoma (Malayan Pit Viper), manufactured by BioFarma Pharmaceuticals, Bandung, Indonesia.
Determination of antivenom, venom and isolated toxin concentrations.
Venoms and isolated toxins were quantified at 280 nm using the Nanodrop Spectrophotometer 2000/2000c (ThermoFisher, Rockford, IL, USA), assuming standard protein absorbance behavior. Antivenom concentrations were determined by bicinchoninic acid (BCA) assay according to the manufacturer’s instructions. Venoms and isolated toxins were prepared at a stock concentration of 1 mg/ml for subsequent assays. Protein concentration of Philippine Cobra Antivenom (PCAV), N. kaouthia Monovalent Antivenom (NkMAV), Neuro Bivalent Antivenom (NBAV) and Serum Anti Bisa Ular (SABU) were determined using the Thermo Scientific BCA (bicinchoninic acid) Protein Assay Kit (Thermo Scientific Pierce, Waltham, MA, USA). Bovine serum albumin (BSA) was used to obtain a standard curve, according to the manufacturer’s protocol. Antivenom concentrations of samples were determined in three independent experiments, and absorbance values were expressed as means ± S.E.M. The concentrations of PCAV, NkMAV, NBAV and SABU were determined to be 16.2 mg/ml, 57.54 mg/ml, 22.91 mg/ml and 238.76 mg/ml, respectively. Antivenom concentrations were further prepared at a stock concentration of 10 mg/ml and subsequently diluted to 1:450, standardized based on Tan et al. [22].
Antivenom immunoreactivity study.
The immunoreactivity of Philippine Cobra Antivenom (PCAV), N. kaouthia Monovalent Antivenom (NkMAV), Neuro Bivalent Antivenom (NBAV) and Serum Anti Bisa Ular (SABU) were examined with indirect enzyme-linked immunosorbent assay (ELISA) for the above-stated venoms and isolated toxins. For PCAV immunoreactivity, venoms of N. philippinensis and C. rhodostoma were used as the positive and negative controls, respectively. Positive controls for NkMAV, NBAV and SABU were respective homologous venoms, N. kaouthia, N. atra and N. sputatrix.
In the ELISA experiment, the immunoplate wells were first coated with 10 ng of the respective venoms and isolated toxins (resuspended in the carbonate-bicarbonate coating buffer, pH 9.6) overnight at 4°C. The excess solution was removed by rinsing the wells four times with washing buffer (phosphate-buffered saline with 0.05% Tween-20, pH 7.4). 100 μl of antivenoms (PCAV, NkMAV, NBAV or SABU) at a dilution of 1:450 were added into the venom- or NTX-coated wells, followed by incubation for 1 hr at room temperature. The fixed dilution was selected based on prior optimization experiments to achieve near-saturation binding conditions suitable for comparative antigen-recognition profiling, rather than for quantitative antibody titer determination. The wells were washed four times with washing buffer, flicked dry, followed by addition of horseradish peroxidase (HRP)-tagged secondary antibody (anti-horse HRP-IgG, 1:10000 (Jackson ImmunoResearch Inc. (West Grove, PA, USA) to each well. The mixtures were then incubated at room temperature for another hour and washed four times with wash buffer before adding 50 μl of TMB (3, 3,’ 5, 5’-tetramethylbenzidine) (Merck, Kenilworth, NJ, USA), as the substrate. The enzymatic reaction was allowed to proceed for 25 min at room temperature (25 °C) in the dark, and subsequently terminated with 50 μL of 0.2 M sulfuric acid. The signals developed were read as absorbance at 450 nm using a Tecan M1000Pro Multimode plate reader (TECAN, Switzerland). The immunological binding activities of antivenom to venoms and isolated α-neurotoxins were interpreted by absorbance unit at 450 nm. The assays were performed in three independent experiments, and absorbance values were expressed as means ± S.E.M.
Heatmap analysis.
Mean ELISA absorbance values (A₄₅₀) obtained for each antivenom–toxin and antivenom–venom combination were normalized by row z-score transformation and visualized as clustered heatmaps using Perseus (version 2.1.5.0). Clustering of both rows (antivenoms) and columns (venoms or isolated α-neurotoxins) was performed using Euclidean distance and average linkage. The red–white–blue color scale represents relative reactivity, with red indicating stronger and blue weaker binding compared with the mean response of each antivenom.
Statistical analysis
Values were expressed as means ± SEM of three independent experiments. Differences between absorbance values of isolated alpha-neurotoxins were statistically evaluated using one-way ANOVA with Bonferroni’s post hoc test. Results were statistically significant at p-value < 0.05.
Multiple sequence alignment.
Jalview software (version 2.11.1.3) [28] and the MUSCLE (Multiple Sequence Comparison by Log-Expectation) [29] tool were used to align multiple sequences. Multiple sequence alignment was performed using sequences from related species obtained from the UniProtKB ory (http://www.uniprot.org/) and with reference to transcriptomics reported earlier [30,31]. Other than sequences matched to NTXs experimentally tested in ELISA, homologous SNTX and LNTX sequences were recruited from public databases to provide a broader evolutionary and motif-based context.
Phylogeny analysis.
Sequences of short-chain alpha-neurotoxins annotated for Asian elapids (retrieved from Universal Protein Knowledgebase (UniProtKB) (accessed on: January 18, 2025) and transcriptome of N. sumatrana [30] were retrieved to construct a phylogenetic tree. The tree was reconstructed using [32] maximum likelihood analysis with bootstrapping (100 replications) in the advanced mode of the phylogeny.fr web server (http://www.phylogene.fr/) (accessed on 20 January 2025), incorporating MUSCLE (v3.7) for multiple alignments, Gblocks (v0.91b) for alignment curation, and PhyML (v3.0) for tree building. Graphical representation and edition of the tree were performed using TreeDyn (v198.3).
Epitope predictions
Linear B-cell epitopes were predicted using BepiPred-2.0 (threshold = 0.5) and the Emini surface accessibility scale (threshold = 1.0), implemented via the Immune Epitope Database (IEDB) analysis resource. Conformational epitopes were evaluated using DiscoTope 2.0 (threshold = –7.7) based on the corresponding structural models. Four short α-neurotoxins (SNTXs) were selected for epitope analysis, comprising three naturally occurring cobrotoxins from Asiatic cobras: P59276 (Naja kaouthia), P80958 and P60770 (Naja atra), and one synthetic construct (ScNTX; PDB: 7LUW). These toxins were chosen based on the availability of (i) complete amino acid sequences in the UniProtKB database and (ii) corresponding experimentally determined three-dimensional structures in the Protein Data Bank (PDB), enabling both sequence-based and structure-based epitope prediction.
Results
Immunoreactivity of PCAV toward Southeast Asian elapid venoms and isolated alpha-neurotoxins
PCAV showed varying immunoreactivity toward different short-chain and/or long-chain alpha-neurotoxins (SNTX and LNTX, respectively) isolated from the venoms of four Asian cobras (N. philippinensis, N. kaouthia, N. sputatrix, and N. atra), sea snakes (H. curtus and H. schistocus), sea krait (L. colubrina) and King Cobra (O. bungarus) (Fig 1). The highest immunoreactivity was observed in N. philippinensis venom (positive control) and its SNTX (abs ≈ 2.7-2.9). The immunoreactivity of PCAV significantly reduced toward the SNTXs of other Asiatic cobras in the following order: N. kaouthia (abs ≈ 2.2) > N. sputatrix (abs ≈ 1.7) > N. atra (abs ≈ 1.4). The immunoreactivity was low toward L. colubrina SNTX (abs: ≈ 0.5), and negligible toward the SNTXs of H. curtus and H. schistocus (abs < 0.1). PCAV also showed minimal immunoreactivity toward the LNTXs of N. kaouthia and O. hannah (abs ≈ < 0.1). Statistically, the immunoreactivity of PCAV toward most heterologous SNTXs and LNTXs was significantly lower compared to the homologous N. philippinensis (one-way ANOVA with multiple comparisons versus control; **p < 0.001)
PCAV binding was measured by indirect ELISA against N. philippinensis venom (homologous venom control), short-chain α-neurotoxins (SNTX) from indicated species, and long-chain α-neurotoxins (LNTX). Bars represent mean absorbance at 450 nm ± SEM (n = 3). Statistical significance was assessed by one-way ANOVA with multiple comparisons versus the homologous N. philippinensis venom control; ns, not significant; p < 0.05, *p < 0.01, **p < 0.001. Abbreviations of genera: N: Naja, for true cobra; H: Hydrophis, for sea snake; L: Laticauda, for sea krait; O: Ophiophagus, for King Cobra.
Immunoreactivity of regional antivenom products toward Southeast Asian elapid venoms and isolated alpha-neurotoxins
Fig 2 shows the comparative immunoreactivity of NkMAV, NBAV and SABU toward the three homologous cobra venoms (N. kaouthia, N. atra, and N. sputatrix, respectively), and alpha-neurotoxins isolated from different elapid species as profiled in Fig 1. NkMAV, raised against the Thai Monocled Cobra, and NBAV, raised against the Taiwan Cobra and Taiwan Krait, showed relatively high immunoreactivity toward the venoms of N. kaouthia, N. atra and N. sputatrix (Abs ≈ 3.0), with no significant difference between the two antivenoms. SABU, raised against the Javan Spitting Cobra, Banded Krait and Malayan Pit Viper, had significantly lower immunoreactivity (Abs ≈ 1.8-2.0) toward the three cobra venoms (including its own homologous N. sputatrix venom) compared to NkMAV and NBAV (p < 0.05).
Values were expressed as means ± SEM from three independent experiments. Abbreviation of genus: N: Naja, for true cobra; H: Hydrophis, for sea snake; L: Laticauda, for sea krait; O: Ophiophagus, for King Cobra. Values were expressed as means ± SEM from three independent experiments. Different letters indicate significant differences among antivenoms within each venom or toxin antigen group (two-way ANOVA followed by Tukey’s post-hoc test, p < 0.05).
When tested against isolated SNTX, NkMAV showed significantly lower immunoreactivity (Abs ≈ 1.2-1.5) than NBAV (Abs ≈ 2.5-3.0) toward the SNTXs of N. kaouthia and N. sputatrix, whereas both antivenoms show comparable immunoreactivity toward the SNTX of N. atra (Abs ≈ 1.8). SABU showed significantly lower immunoreactivity than NkMAV and NBAV toward the SNTXs of N. kaouthia, N. atra, and N. sputatrix (Abs ≈ 0.4-0.8). Of note, NkMAV, NBAV and SABU all exhibited low immunoreactivity toward SNTXs of N. philippinensis and the marine elapids (H. curtus, H. schistosus, L. colubrina) (Abs < 0.5). Overall, NkMAV was significantly more immunoreactive than NBAV and SABU toward its homologous LNTX (isolated from N. kaouthia venom), whereas all three antivenoms showed weak binding to the LNTX of the King Cobra.
Heatmap analysis and hierarchical clustering
Clustered heatmaps (Fig 3) summarized the immunoreactivity profiles of the four regional antivenoms. In the venom panel (Fig 3A), PCAV displayed the strongest homologous binding to N. philippinensis venom, whereas NkMAV and NBAV reacted most strongly with N. kaouthia, N. atra, and N. sputatrix venoms. SABU showed generally weaker responses across species. In the toxin panel (Fig 3B), similar clustering patterns were observed: the Philippine cobra SNTX formed a distinct branch separated from the mainland Asian SNTXs, while marine SNTXs and LNTXs from N. kaouthia as well as O. bungarus grouped independently, reflecting negligible cross-recognition by all antivenoms. Overall, the clustering corroborated the geographical and species specificity of immunoreactivity patterns observed in the ELISA assays.
Color intensity corresponds to row z-scored ELISA absorbance (A₄₅₀) values, with red indicating higher-than-average and blue lower-than-average binding for each antivenom. Abbreviations: PCAV, Philippine Cobra Antivenom; NKMAV, Naja kaouthia Monovalent Antivenom; NBAV, Neuro Bivalent Antivenom; SABU, Serum Anti Bisa Ular; SNTX, short-chain alpha-neurotoxin; LNTX, long-chain alpha-neurotoxin.
Multiple sequence analysis of alpha-neurotoxins
Amino acid sequences of short alpha-neurotoxins tested for antivenom immunoreactivity were aligned and compared in Fig 4. All SNTX sequences reveal the conserved eight cysteine residues, which result in four disulfide bridges responsible for the folding and stability of a three-finger protein structure. Residues critical for nAChR binding were indicated at the tip of loop II, while residues with high variability and non-consensus within or adjacent to the region were highlighted (in purple boxes). With numbering based on cobrotoxin of N. atra (UniProt: P60770, 62 amino acid residues), the 28th, 30th, 35th, 36th, and 37th residues show variability and substitutions. Within the cobra species, two subsets based on the amino acid variation within this region can be recognized, as follows: W28 paired with S30 and 35TII37, or R28 paired with R30 and 35YRT37. The corresponding residues in the SNTX of two true sea snakes (H. schistosus and H. curtus) were conserved (T28, S30, 35TRI37), whereas in that of the sea krait (L. laticauda), the SNTX has Q28, R30, and 35SIT37 within this peptide region. The K27 residue and residues between the two motifs of the respective subsets, namely 31DHRG34, remained highly conserved within this critical region of nicotinic receptor binding.
Loops I–III and the C-terminal region are indicated above the alignment. Conserved cysteine residues forming the characteristic disulfide-bonded scaffold of three-finger toxins are shown. Solid arrows indicate primary residues directly implicated in nicotinic acetylcholine receptor (nAChR) binding, whereas dashed arrows denote supporting residues contributing to receptor interaction. The boxed region highlights sequence variability within the receptor-binding motif located in loop II. Conservation scores are shown below the alignment.
The amino acid sequences of SNTX from multiple lineages of Elapidae, including cobras (Naja spp., along with their subgenera), mambas (Dendroaspis spp.), coral snakes (Micrurus spp.), sea snakes (Hydrophis spp.), sea kraits (Laticauda spp.), and the Australian elapid Suta nigriceps, as well as the synthetic construct ScNTX, were retrieved from UniProtKB and PDB databases, respectively. The sequences were further aligned for consensus analysis shown in Fig 5. It should be noted that Fig 5 incorporates additional homologous SNTX sequences retrieved from UniProtKB for broader comparative analysis. These additional sequences were not part of the ELISA-based immunoreactivity experiments but were included to illustrate motif conservation and divergence across elapid lineages.
Loops I–III and the C-terminal region are indicated above the alignment. Conserved cysteine residues forming the disulfide-bonded scaffold characteristic of three-finger toxins are shown. Residues are shaded according to BLOSUM62 similarity. Solid arrows denote primary residues implicated in nicotinic acetylcholine receptor (nAChR) binding, whereas dashed arrows indicate supporting residues contributing to receptor interaction. The boxed region highlights sequence variability within the receptor-binding motif located in loop II. Conservation scores are shown below the alignment.
All sequences in Fig 5 retained the characteristic eight-cysteine framework, forming four disulfide bridges that stabilize the three-finger toxin structure. The sequence alignment revealed more variations (specifically, having a lower consensus) in the receptor-binding motif, particularly within loop II, where substitutions were highlighted in purple boxes. Based on numbering relative to Naja atra cobrotoxin (P60770, 62 amino acids), key positions of variation were primarily identified at residues 28, 30, 35, 36, and 37, consistent with Fig 4, notwithstanding greater diversity. The two subset motifs shown in Fig 4, i.e., 28WWS30----35TII37, and 28RWR30----35YRT37, appear to be consistently present in Asiatic cobras (subgenus: Naja) except for the variation noted in N. sumatrana (GWR pairing YRI). Here, a schematic overview of the geographic distribution and divergence of representative cobra SNTX motif types is provided in S2 File. On the other hand, the SNTXs of African species exhibit various combination motifs, as in Q/RWR----TII in subgenus Uraeus, VWR----TII in subgenus Afronaja, and QWS----TII in Boulengerina. The African mambas and New World coral snakes too exhibit variation in the two residues (28th and 30th residues based on numbering by P60770); e.g., YWR and TWS in Dendroaspis spp., TWR and SWS in Micrurus spp. while sharing the conserved TII motif. In the marine elapids, these motifs are more divergent from the terrestrial elapids, where true sea snakes (Hydrophis spp.) show TWS----TRI and sea krait (Laticauda sp.) show QWR----SIT. The synthetic ScNTX contains a TWR----TII motif in this corresponding region, and exhibits the highest sequence similarity to the SNTX of S. nigriceps, an Australian terrestrial elapid of the Hydrophiinae subfamily in which marine elapids are nested. The overall sequence comparison also reveals conserved N-terminal sequences of SNTX specific to different clades, notable in cobras, where it is typically LECHNQQS in Asiatic cobras and, with minor substitution, MICHNQQS and MECHNQQS in most African cobras. The mambas, New World coral snakes, and Hydrophiinae species show less conserved N-terminus sequence from those of the cobras while retaining the cysteine residue at the 3rd residue position.
The amino acid sequences of representative short neurotoxins (SNTXs) from representative cobra species and a sea snake were aligned alongside long neurotoxins (LNTXs) from Monocled Cobra (Naja kaouthia), King Cobra (Ophiophagus bungarus), and Many-banded Krait (Bungarus multicinctus) in Fig 6. The sequence alignment highlights conserved features essential for toxin structure and receptor interaction, as well as key regions of divergence that differentiate SNTXs from LNTXs within the three-finger protein family. All sequences maintain the three-finger loop configuration through conserved cysteine framework and disulfide-stabilized three-finger structure (brackets). Of note, the LNTXs contain an additional disulfide bond in loop II, absent in all SNTXs. The loop III and C-terminal regions of LNTXs also show greater divergence, with several charged and hydrophobic substitutions.
SNTXs from cobras and sea snake are aligned with LNTXs from Monocled Cobra, King Cobra, and Multi-banded Krait. Loops I–III and the C-terminal region are indicated above the alignment. Conserved cysteine residues forming the characteristic disulfide-bonded scaffold of three-finger toxins are shown; note the additional cysteine pair in loop II of long-chain neurotoxins, corresponding to an extra disulfide bond. Residues are shaded according to BLOSUM62 similarity. Solid arrows indicate primary residues implicated in nicotinic acetylcholine receptor (nAChR) binding, whereas dashed arrows denote supporting residues contributing to receptor interaction. Purple boxes highlight sequence variability within the receptor-binding motif of the two cobra SNTXs. Conservation scores are shown below the alignment.
A low consensus region marked by differences in the receptor-binding region of loop II is observed, especially within cobra SNTXs, which exhibit two distinct motifs, as described in Figs 3 and 4: 28WWS30----35TII37 (P60773, N. philippinesis) and 28RWR30----35YRT37 (P60770, cobrotoxin of N. atra). In the hydrophiid SNTXs, the motifs are apparently more varied from cobras, e.g., substitutions resulting in TWS----YRI (P68415, H. schistosus), and TWR----YII (ACY68680, S. nigriceps). LNTXs exhibit greater divergence, including additional hydrophobic and charged residues beyond position 40, as well as an additional disulfide bond, which contribute to a potentially extended receptor interaction site.
Phylogenetic analysis of short alpha-neurotoxins
A maximum likelihood phylogenetic tree was reconstructed to evaluate the evolutionary relationships of short-chain α-neurotoxins (SNTX) across representative elapid taxa, including marine, terrestrial, and arboreal lineages (Fig 7). The analysis reveals well-resolved clades that correspond to extant taxonomic groups, and illustrates the molecular diversification of SNTX sequences within and across the elapid lineages. The SNTXs of sea snakes (H. curtus and H. schistosus) forms a distinct and well-supported marine clade that is positioned close to the Australian elapid (S. nigriceps), whereas the African mambas (Dendroaspis polylepis and Dendroaspis viridis), and New World coral snakes (Micrurus frontalis and Micrurus laticollaris) form neighboring but separate clusters within the same broader elapid SNTX assemblage. It is worth noting that the hydrophiid (sea snake) lineage (Hydrophis spp.) appear divergent from the SNTXs of sampled elapids, indicating a distinct evolutionary trajectory for their SNTX. This, however, does not imply that sea snakes are more “primitive”; rather, their SNTX sequence placements reflect divergence from that of a common elapid ancestor before the diversification of the terrestrial cobra-mamba-coral snake lineage. Their evolution as marine specialists suggests subsequent adaptation rather than ancestral retention of features.
The dataset includes mambas (Dendroaspis polylepsis, Dendroaspis viridis), coral snakes (Micrurus frontalis, Micrurus laticollaris), sea snakes (Hydrophis curtus, Hydrophis schistosus), an Australian elapid (Suta nigriceps), and true cobras (Naja spp.). Cobra sequences comprise Asian cobras of the subgenus Naja (Naja sputatrix, Naja kaouthia, Naja sumatrana, Naja atra, Naja philippinensis, Naja samarensis), African cobras of the subgenus Uraeus (Naja nivea, Naja haje), Boulengerina (Naja melanoleuca), and subgenus Afronaja (Naja pallida). The sequence 7LUW_ScNTX represents the previously reported synthetic short neurotoxin construct [33]. Sequences marked with an asterisk (*) denote basal position of SNTX variants bearing the distinctive epitope motif “WWS----TII”, in contrast to the derived “RWR----YRT/I” motif found in other Southeast/East Asian cobras. The tree was inferred using the maximum likelihood method implemented in PhyML (v3.1/3.0 aLRT), and visualized using TreeDyn (v198.3).
In the phylogenetic analysis, the synthetic short neurotoxin construct (7LUW_ScNTX) was introduced into the tree for comparison and was found positioned outside the main Naja radiations, resolving closer to the node associated with the assemblage comprising sea snakes (Hydrophis), the Australian elapid (Suta), mambas (Dendroaspis), and coral snakes (Micrurus). The true cobras (Naja) formed a distinct clade and were further partitioned into major lineages, broadly consistent with their geographic and subgeneric divergence. Within this cobra clade, the Asian cobras of the subgenus Naja showed further differentiation, including a small basal assemblage (marked with an asterisk) which comprises sequences from N. philippinensis and N. samarensis, together with selected SNTX variants from other Asian cobras.
Epitope prediction of short alpha-neurotoxins
Fig 8 shows broadly similar linear epitope profiles among the four SNTXs, with all toxins displaying a dominant antigenic region spanning the N-terminal half to central portion of the sequence in the BepiPred-2.0 analysis (Fig 8A), together with additional surface-accessible regions in the Emini plot (Fig 8B), and motif variants in loop II (Fig 8C). Notably, the two SNTXs bearing “WWS----TII” motif in loop II, i.e., P59276 from N. kaouthia and P80958 from N. atra, show highly similar profiles in both the extent and continuity of their predicted linear epitopes, supporting relative conservation of antigenic features despite originating from different species. In contrast, the SNTX with a “RWR----YRT” motif (P60770) from N. atra exhibits a shifted and somewhat more segmented surface accessibility pattern, with stronger central reactivity and a distinct reduction in the N-terminal accessible region, suggesting altered local antigenic presentation associated with the “RWR----YRT” motif class. The synthetic construct ScNTX, which contains the intermediate TWR----TII motif, shows a mixed profile: its BepiPred pattern remains broadly similar to the native toxins, whereas its Emini plot more closely resembles the extended and discontinuous accessibility pattern seen in P60770. Together, these results suggest that SNTXs bearing “WWS----TII” motif retain a more conserved linear antigenic architecture, whereas substitution toward RWR----YTR is associated with measurable changes in predicted epitope continuity and surface exposure, consistent with emerging antigenic divergence between the two motif classes.
Linear B-cell epitope propensity and surface accessibility of four short α-neurotoxins (SNTXs): P59276 (Naja kaouthia), P80958 and P60770 (Naja atra), and ScNTX (synthetic construct), were predicted using the IEDB analysis resource. (A) BepiPred-2.0 (threshold = 0.5). (B) Emini surface accessibility scale (threshold = 1.0). Predicted epitope regions are highlighted in yellow. (C) Loop II motif variants (WWS----TII, RWR----YRT, TWR----TII) associated with antigenic divergence.
Fig 9 A-B shows structure-based epitope predictions that further distinguish antigenic features between “WWS----TII” and “RWR----YRT” motif classes (Fig 9C). In Fig 9A, DiscoTope analysis indicates that all SNTXs possess dominant conformational epitopes in loop II; however, the “WWS----TII” toxins (P59276 and P80958) exhibit relatively confined high-scoring regions centered at the loop II apex, whereas the “RWR----YRT” toxin (P60770) displays a broader and more continuous distribution of positive scores extending along loop II and in loop III. The synthetic construct (ScNTX; TWR----TII) shows an intermediate profile, retaining a prominent loop II epitope while exhibiting extended continuity similar to the “RWR----YRT” toxin. These differences are further reflected structurally in Fig 9B, where epitope mapping reveals localized exposure at the loop II tip in “WWS----TII” toxins, in contrast to the more extensive surface distribution across loop II and adjacent regions, including loop III, in P60770 and ScNTX. Together, these findings indicate that substitution from WWS----TII to RWR----YRT motifs is associated with expansion and redistribution of conformational epitopes, supporting a structural basis for antigenic divergence among SNTX variants.
Structure-based epitope prediction of the same four SNTXs using DiscoTope 2.0 and corresponding PDB structures (1JE9, 1ONJ, 1COE, and 7LUW). (A) DiscoTope scores (threshold = –7.7; red line), with positive residues shown in green. (B) Structural mapping of predicted epitope residues (yellow) on toxin models in Jmol mode. (C) Loop II motif variants (WWS----TII, RWR----YRT, TWR----TII) associated with antigenic divergence.
Discussion
Alpha-neurotoxins (α-NTXs), comprising long-chain (LNTX) and short-chain (SNTX) neurotoxins, are functionally conserved snake venom proteins that show potent antagonistic activity toward muscle-type nicotinic acetylcholine receptors (nAChRs) [34]. While this function appears to have evolved convergently across multiple elapid lineages as an adaptation for predation, α-NTXs are evolutionarily labile. Positive selection, driven primarily by past and perhaps ongoing evolutionary arms race, subjects these proteins to accelerated evolution [8]. This evolutionary dynamic has led to substantial sequence diversification, particularly at surface-exposed residues across elapid species, while preserving the structural framework essential for receptor binding. In comparison to SNTXs, LNTXs have traditionally received more attention owing to their higher binding affinity toward human muscle nicotinic receptor (nAChR) and thus, a “perceived” higher risk of envenomation in human [17]. Nonetheless, SNTXs are increasingly recognized for their limited immunogenic capacity (in comparison to LNTXs) [3,19,33], and the high abundance in the venoms of some Asian Naja species, particularly those from Southeast and East Asia, simply cannot be overlooked [12–14,19]. Previous studies attributed the poor immunogenicity of SNTX to its small size (~60–62 amino acids), an inherent factor limiting epitope display for effective immune response [20,35]. Beyond the molecular size of the SNTX, in this study, we showed that SNTXs display subtle sequence-level variations that may critically influence their antigenicity and thus, impacting the effectiveness of antivenom therapy. As revealed in a series of Asiatic cobra venomics, there is a transition from LNTX- to SNTX-dominant phenotype as cobras diversified from the west to the east, with the easternmost dispersal lineage of Naja spp., represented by N. philippinensis and N. samarensis of the Philippines, characterized by extremely lethal venoms containing exceptionally high abundance of SNTXs (44–66%) with no LNTXs [12,13]. The same is true for N. atra, albeit with a lower abundance of SNTX (~10%) and lower lethality [14,23]. Intriguingly, the Philippine spitting cobra venom could not be effectively cross-neutralized by antivenom raised against N. atra, suggesting antigenic variation between the two. On the other hand, the venoms of other Asian Naja spp. had lower abundances of SNTXs, typically ranging from 1-10% of total venom protein (Table 1). The remarkable variation in both abundance and epitope composition of SNTXs between the Philippine species and other Asian cobras may explain the reduced immunoreactivity of PCAV toward venoms and isolated SNTX of these Southeast Asian cobras.
Based on the previous study evaluating the neutralizing activity of Philippine Cobra Antivenom (PCAV) against the venoms of Naja samarensis and Naja philippinensis [22], the present immunoreactivity findings confirm that these far-eastern, insular cobras endemic to the Philippines possess SNTXs with distinct antigenic profiles, differentiating them from other Southeast Asian cobras. Notably, PCAV showed markedly reduced cross-reactivity toward SNTXs from non-Philippine cobra species, following the order: N. kaouthia > N. sputatrix > N. atra. This pattern may reflect historical biogeographic dispersal, in which the Philippine cobra species could have descended from an ancestral lineage in continental Asia that radiated southward and eastward, with N. kaouthia and N. sputatrix representing intermediate lineages, while N. atra diverged along an eastward trajectory into mainland China approximately 1–2 Mya, and subsequently reached Taiwan during the Late Pleistocene glacial periods (~20,000–70,000 years ago) before the submersion of the land bridge. In Taiwan’s insular and montane environments, further ecological adaptation in N. atra might have resulted in a venom phenotype that includes SNTXs with antigenic features that are much more divergent from their Philippine counterparts. In fact, even within the mountainous island of Taiwan, the Central Mountain Range was speculated to be a biogeographic barrier that resulted in two variable phenotypes between the eastern and western N. atra populations, as reported in both their morphology and venom compositions [14,47]. The present study also confirmed the very limited cross-reactivity of PCAV toward SNTXs of marine elapids, including sea kraits and sea snakes, as well as LNTXs from both N. kaouthia (a true cobra) and O. bungarus (King Cobra) in Southeast Asia due to greater variation in their sequences and epitopes.
We also further evaluated the immunorecognition of αNTXs by other cobra antivenoms available in the region: N. kaouthia Monovalent Antivenom (NkMAV, Thailand), Neuro Bivalent Antivenom (NBAV, Taiwan), and Serum Anti Bisa Ular (SABU, Indonesia). The present ELISA design employed a fixed, near-saturating antivenom dilution to compare relative antigen recognition patterns rather than quantitative antibody titers or binding affinities. NkMAV showed significantly higher immunological binding activity among the antivenoms toward LNTXs of N. kaouthia, which is intuitively appropriate as the Thai N. kaouthia venom is used as its immunizing venom. Furthermore, in comparison to various other southeast Asian cobras including its own species from other geographical locales, the Thai N. kaouthia venom contains the highest abundance of LNTXs (35% of total venom protein) [15]. Hypothetically, NkMAV is an LNTX-targeting antivenom for cobra species within the region, e.g., N. sumatrana, which also shares a similar LNTX-dominant venom phenotype. Indeed, NkMAV is used clinically as the antivenom treatment in Malaysia where N. kaouthia and N. sumatrana are both found [48], with success to some extent. However, NkMAV is not not indicated for envenoming by King Cobra (O. hannah and O. bungarus) in spite of its LNTX-dominant venom phenotype, since King Cobra’s and Naja cobra’s LNTXs are evolutionarily and antigenically diverged [49]. While exhibiting high immunoreactivity toward the N. kaouthia LNTX, NkMAV consistently showed a lower immunoreactivity by at least 30% toward the SNTXs of its own and heterologous N. sputatrix as well as N. atra, implying that an “LNTX-targeting” antivenom, as proposed above, has weak binding activity for SNTX of these cobras. On the other hand, NBAV, raised against Taiwan Cobra venom, which contains SNTX as its sole alpha-neurotoxin [14,23], exhibited higher binding activities toward these SNTXs. Meanwhile, NBAV’s binding activity toward the LNTX is, unsurprisingly, significantly lower than NkMAV. The finding further supports that LNTX and SNTX are indeed antigenically variable, with the latter (SNTX) having a lower immunogenicity than LNTX [20]. The Indonesian SABU antivenom, however, had the overall lowest immunoreactivity toward all alpha-neurotoxins, a finding consistent with its polyvalent (trivalent) nature (having the smallest portion of SNTX from N. sputatrix), and its lower content of immunoglobulins, immunological binding activity as well as neutralization efficacy [50]. Finally, a finding that prompted the question of antigenic divergence in the SNTXs of southeast Asian cobras: all three antivenoms (NkMAV, NBAV, SABU) lacked immunoreactivity toward the SNTXs of N. philippinensis and marine elapids, highlighting species-specific and biogeographically influenced epitope variation in cobra SNTXs. The lack of immunoreactivity suggests limited cross-neutralization potential; however, establishing direct in vivo correlations would require systematic cross-neutralization studies in animal models. Given the low cross-reactivity observed among several heterologous antivenoms, these experiments were not pursued, and the present work instead focuses on mechanistic insights into antigenic divergence at the molecular level.
The heatmap visualization highlights the antigenic divergence between the Philippine and other Asian cobra neurotoxins. The strong homologous binding of PCAV to N. philippinensis SNTX contrasts with the limited cross-recognition by other regional antivenoms, supporting the notion that short-chain α-neurotoxins have evolved with geographically distinct antigenic epitopes. NkMAV and NBAV clustered closely, indicating shared recognition of major SNTXs from N. kaouthia, N. atra, and N. sputatrix, whereas all antivenoms showed weak recognition of long-chain α-neurotoxins, particularly O. bungarus LNTX. The finding implies that current immunization mixtures primarily reflect the SNTX antigenic profiles of regional cobras, leading to restricted cross-neutralization, and reinforces the need to incorporate representative antigens from both SNTX motif lineages to broaden antivenom coverage.
Although SNTXs constitute the dominant lethal component in the venoms examined, whole-venom neutralization in clinical settings is inherently multifactorial. Minor venom constituents may synergize to enhance toxicity and influence the overall immunogenic profile of the venom used for antivenom production. The present study focuses on isolated SNTX fractions to dissect subtype-specific antigenic variation, while acknowledging that this reductionist approach may not fully recapitulate the complexity of whole-venom interactions during envenoming or immunotherapy. Here, given that the observed antigenic divergence most plausibly arises from epitope variability among SNTXs, we further aligned and analyzed the SNTX sequences to determine whether specific motif-level differences might serve as drivers of antigenic subclasses. Rather than modeling every experimentally tested toxin individually, structurally characterized SNTXs carrying either the “WWS–TII” or “RWR–YRT” motif were chosen as representatives to evaluate whether these motif-level differences may translate into altered antigenic surface exposure. The synthetic scNTX sequence, previously designed to represent a consensus short-chain α-neurotoxin construct, was included as a comparative reference in sequence alignment and in silico epitope analyses. The sequence analysis reveals two dominant loop II motifs in Asian cobras: “28WWS----TII37” and “28RWR----YRT37”, between which the sequence “31DHRD34” remained highly conserved across various lineages. N. philippinensis and N. samarensis expressed SNTXs with only the “28WWS----TII37” motif, whereas N. atra (Taiwan) and N. kaouthia (Thailand) express two forms of SNTXs, each contains “28WWS----TII37” and “28RWR----YRT37”, respectively, with the latter form “28RWR----YRT37” being the majority. The N. sputatrix (Indonesia) SNTX contains only the “28RWR----YRT37” form of SNTX, while that of N. sumatrana (Malaysia) in this study revealed a variation in this motif as “28GWR----YRI37”. The 28th glycine (28G) or arginine (28R) residue has a different property from the tryptophan residue (28W) which contains a large hydrophobic, double-ring aromatic side chain. As glycine is small, the GWR motif may simply unmask or provide flexibility to the bulky WR pair next to it, maintaining a similar shape to the “28RWR----YRT37” motif of N. sputatrix, which is also shared between N. kaouthia (Thailand) and N. atra (Taiwan) as their major form of SNTX. These dichotomous motifs agree with the variable immunoreactivity of PCAV that binds effectively to SNTX containing the motif “28WWS----TII37” but not “28RWR----YRT37”, while the reverse is true for NBAV, NKMAV, and SABU (i.e., binding effectively to SNTX having the motif 28RWR----YRT37” but not “28WWS----TII37”. The finding suggests an epitope-level divergence between the two motifs in these cobra SNTXs despite sharing relatively close phylogenetic relatedness and biogeographic proximity in Southeast Asia and East Asia. On the other hand, the SNTXs of African cobras vary from those of the Asiatic species to a much greater extent, whereby some of the 28th amino acid residues are substituted by glutamine (Q) or valine (V) while retaining the conserved region of 29W and 30R/30S residues within the motif. The African mambas, New World coral snakes, and hydrophiid species have an even more variable combinations of the motif (28XWX30) within this critical region of loop II, further indicating that although this functional region is broadly conserved for nAChR binding [16], surface-exposed residues in and around the loop can mutate and diverge antigenically. Ostensibly, the mutation begat variable epitopes which brought advantage in a predator-prey arms-race, as these cobras of different species adapt to distinct ecological niches throughout Asia and Africa. Interestingly, the synthetic construct (ScNTX) harbors the motifs of “28TWR30” and “35TII37” (along with the all-conserved “31DHRG34” motif) in its loop II, which are, by sequence comparison, highly similar (nearing 100%) to the SNTX of an exotic and endemic terrestrial elapid, S. nigriceps from Australia. Its “28TWR30” motif, in comparison to the abovementioned “28RWR30” and “28WWS30” motifs of Asiatic cobras’ SNTXs, deserves a note of distinction in terms of their structure and antigenicity. Both the constructed “28TWR30” and the native “28RWR30” contain tryptophan (W) and arginine (R) at positions 29 and 30, with only one residue difference, i.e., threonine (T) vs. arginine (R) at position 28. Threonine is smaller and polar, while arginine is larger and basic. Still, the difference is not as drastic as introducing a tryptophan (W) as in the case of the “28WWS30” motif, which contains two bulky tryptophan residues—this could alter the local conformation significantly. Also, its 30th residue is substituted by serine (S), an uncharged polar residue, unlike the basic (typically also more antigenic) arginine (R) at position 30. Hence, both “28TWR30” and “28RWR30” should have a higher potential to form a similar antigenic surface. At the same time, the “28WWS30” motif contributes to a surface with higher hydrophobicity and lower charge, resulting in lower antigenic similarity to the other two and ultimately facilitating antigenic escape.
On the other hand, the secondary variable motif “35TII37” is conserved with that of the SNTXs carrying “28WWS30” motif (notably in N. philippinensis and N. samarensis, and in African cobra species). Comparing between “35TII37” and “35YRT37” motifs (the latter is paired with the “28RWR30” motif, predominantly found in N. kaouthia, N. sputatrix, and N. atra), the 35TII37 motif likely contributes to protein core structure or membrane interactions rather than immunorecognition, as this relatively compact region is mostly hydrophobic with low surface exposure for antibody accessibility. Further sequence comparison between representative short neurotoxins (SNTXs) from N. philippinensis, N. atra, H. curtus, and S. nigriceps, and long neurotoxins (LNTXs) from N. kaouthia, O. bungarus (O. hannah), and B. multicinctus revealed greater divergence in residues flanking the critical sites. Notably, in the LNTXs analyzed, the 30th residue is replaced by a cysteine, creating motifs such as 28TWC30 or 28MWC30. This substitution enables the formation of an additional loop, stabilized by a disulfide bond between the cysteine residues at positions 30 and 35. This innovative structural role has a functional implication: a conformational constraint is introduced to stabilize the local structure of loop II, modulating the surface topology and possibly enhancing binding affinity to muscle-type nicotinic acetylcholine receptors (nAChRs) through greater hydrophobic and electrostatic contacts [51].
To place the observed loop II motif divergence into an evolutionary context, we reconstructed the phylogenetic relationships of the analyzed SNTXs. The sequences cluster within the classical type I (short-chain) α-neurotoxin lineage of the three-finger toxin superfamily, consistent with established evolutionary classifications of elapid 3FTxs [52]. Within this lineage, the two major loop II motif classes identified in this study form distinct sub-clusters, suggesting that antigenic divergence corresponds with evolutionary branching rather than random residue variation. The integration of the synthetic sequence provides a comparative anchor to assess the evolutionary polarity of natural sequence changes, especially in structurally and immunologically relevant regions with epitope recognition and receptor binding. The tree supports lineage-specific diversification of SNTXs within the genus Naja, with antigenic divergence accompanying geographic and subgeneric separation. Within the Asian cobra clade (subgenus Naja), the basal SNTX variants are characterized by the distinctive, unique epitope motif “WWS----TII”, whereas the more derived SNTXs predominantly carry the divergent motif “R/GWR----YRT/I”. This topology supports the view that the “WWS----TII” motif represents an earlier SNTX form within the Asian cobra lineage, from which the more antigenically divergent “R/GWR----YRT/I” variants subsequently emerged. The exclusive presence of the basal motif in the Philippine cobras, N. philippinensis and N. samarensis, further suggests retention of an ancestral-like epitope configuration in these endemic, insular species, whereas N. atra, N. kaouthia, and other Asiatic cobras appear to have shifted toward and prioritized the derived form.
Building on this evolutionary framework, the epitope prediction analyses provide structural and functional context for the observed loop II motif divergence. Across both linear and structure-based predictions, loop II consistently emerges as the dominant antigenic region, in line with its established role in receptor binding. However, clear differences are evident between motif classes. The “WWS----TII” toxins exhibit a more confined and localized epitope profile, largely centered at the apex of loop II, whereas the “RWR----YRT” toxin shows a broader and more continuous antigenic surface extending along loop II and in loop III, accompanied by increased surface accessibility. This expansion is recapitulated by the synthetic construct (TWR----TII), which displays an intermediate but more extended epitope architecture. Together, these findings suggest that the evolutionary transition from the ancestral WWS----TII motif to the derived RWR----YRT motif is associated with a shift from localized to more distributed antigenic surfaces, potentially enhancing epitope exposure and variability. Such structural redistribution of antigenic determinants provides a plausible mechanistic basis for the antigenic divergence observed among SNTXs, and may contribute to differences in antibody recognition and cross-reactivity across cobra lineages.
The findings indicate that motif-level differences represent fine-scale diversification within a conserved structural scaffold and parallel the differential immunoreactivity patterns observed experimentally. Overall, the notable variation at positions 28, 30, and 35 occurring within structurally tolerant regions of the cobra alpha-neurotoxins is in line with the “Three-Fingered RAVER” theory (rapid antigenic variation in exposed residues) in the three-finger toxin superfamily [8]. The variation reflects accelerated evolution as an adaptive strategy to diversify antigenicity without compromising receptor binding or venom potency. The identification of divergent loop II antigenic motifs through sequence alignment and in silico epitope prediction tools provides a coherent, robust theoretical framework that aligns with the consistent immunoreactivity patterns observed in this study. While high-resolution structural characterization of antibody-toxin interfaces or targeted mutational analyze would be required to establish a definitive causal relationship between specific residues and antibody escape, the proposed epitope-driven mechanism should be interpreted as a mechanistically supported model rather than conclusive molecular proof.
Considering the high degree of evolvability in this class of toxins, the pursuit of a universal anti-SNTX antivenom that is ubiquitously effective against all SNTX types deserves further and thorough investigation, including the search for non-antibody-based alternatives such as small-molecule inhibitors and de novo designed mini-binders of venom proteins [53,54]. Nonetheless, antivenoms will likely remain the cornerstone of therapy for the foreseeable future. Therefore, optimizing antivenom formulations should involve incorporating a balanced repertoire of anti-LNTX and anti-SNTX antibodies, taking into account not only the structural subtypes of 3FTX toxins but also their relative abundance within the venom proteome, as well as potential epitope variations that may occur even among structurally conserved toxins across geographically distinct species.
Conclusion
This study offers a new perspective on the divergence of cobra venom short-chain alpha-neurotoxins (SNTXs), which exhibit significant antigenic variability despite structural conservation. The Philippine spitting cobras (N. philippinensis and N. samarensis) express SNTXs with an ancestral-like loop II motif (28WWS–TII37), which are strongly recognized by PCAV but poorly by other regional antivenoms. In contrast, Asiatic cobras such as N. kaouthia, N. atra, and N. sputatrix predominantly express a divergent and more derived form of the corresponding motif (28RWR–YRT37), which may contribute to the limited cross-recognition observed for PCAV. Conversely, antivenoms raised against the 28RWR–YRT37 type of SNTX (predominant forms in N. kaouthia, N. atra, N. sputatrix) showed minimal binding toward the 28WWS–TII37 type of SNTX from the Philippine cobras, suggesting limited cross-neutralization potential. These findings underscore that antigenicity differences at key epitope residues, rather than size constraints alone, contribute to the poor recognition of SNTXs. From a clinical perspective, this divergence highlights the challenges of developing a universal anti-cobra antivenom. Together, our findings highlight that SNTX antigenicity is shaped by discrete sequence motifs, which define regional immunoreactivity barriers. Rational antivenom development in the future should integrate these antigenic subtypes alongside LNTXs to broaden antivenom cross-species efficacy.
Supporting information
S1 Table. Short and long alpha-neurotoxins and respective species used in the immunoreactivity study.
https://doi.org/10.1371/journal.pntd.0013859.s001
(PDF)
S2 File. Geographic distribution and antigenic divergence of cobra short-chain α-neurotoxins (SNTXs) associated with species-specific antivenom recognition in Southeast and East Asia.
https://doi.org/10.1371/journal.pntd.0013859.s002
(PNG)
References
- 1.
WHO. World Health Organization guidelines for the production, control and regulation of snake antivenom immunoglobulins. 2018.
- 2. Munshi H, Gajbhiye RK. Strengthening global snakebite data for WHO’s goal for 2030. Lancet. 2024;403(10430):907–8. pmid:38460982
- 3. Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17063. pmid:28905944
- 4. Miwa JM, Ibanez-Tallon I, Crabtree GW, Sánchez R, Sali A, Role LW, et al. lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron. 1999;23(1):105–14. pmid:10402197
- 5. Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium. J Cell Physiol. 2006;208(1):238–45. pmid:16575903
- 6. Arredondo J, Chernyavsky AI, Webber RJ, Grando SA. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol. 2005;125(6):1236–41. pmid:16354194
- 7. Utkin YN. Last decade update for three-finger toxins: Newly emerging structures and biological activities. World J Biol Chem. 2019;10(1):17–27. pmid:30622682
- 8. Sunagar K, Jackson TNW, Undheim EAB, Ali SA, Antunes A, Fry BG. Three-fingered RAVERs: rapid accumulation of variations in exposed residues of snake venom toxins. Toxins (Basel). 2013;5(11):2172–208. pmid:24253238
- 9. Tasoulis T, Isbister GK. A review and database of snake venom proteomes. Toxins (Basel). 2017;9(9):290. pmid:28927001
- 10. Tan CH, Tan KY, Lim SE, Tan NH. Venomics of the beaked sea snake, Hydrophis schistosus: a minimalist toxin arsenal and its cross-neutralization by heterologous antivenoms. J Proteomics. 2015;126:121–30. pmid:26047715
- 11. Kakati H, Patra A, Mukherjee AK. Composition, pharmacology, and pathophysiology of the venom of monocled cobra (Naja kaouthia)- a medically crucial venomous snake of southeast Asia: an updated review. Toxicon. 2024;249:108056. pmid:39111718
- 12. Tan CH, Wong KY, Chong HP, Tan NH, Tan KY. Proteomic insights into short neurotoxin-driven, highly neurotoxic venom of Philippine cobra (Naja philippinensis) and toxicity correlation of cobra envenomation in Asia. J Proteomics. 2019;206:103418. pmid:31201947
- 13. Palasuberniam P, Chan YW, Tan KY, Tan CH. Snake venom proteomics of samar cobra (Naja samarensis) from the Southern Philippines: short alpha-neurotoxins as the dominant lethal component weakly cross-neutralized by the philippine cobra antivenom. Front Pharmacol. 2021;12:727756. pmid:35002690
- 14. Huang H-W, Liu B-S, Chien K-Y, Chiang L-C, Huang S-Y, Sung W-C, et al. Cobra venom proteome and glycome determined from individual snakes of Naja atra reveal medically important dynamic range and systematic geographic variation. J Proteomics. 2015;128:92–104. pmid:26196238
- 15. Tan KY, Tan CH, Fung SY, Tan NH. Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia. J Proteomics. 2015;120:105–25. pmid:25748141
- 16. Nys M, Zarkadas E, Brams M, Mehregan A, Kambara K, Kool J, et al. The molecular mechanism of snake short-chain α-neurotoxin binding to muscle-type nicotinic acetylcholine receptors. Nat Commun. 2022;13(1):4543. pmid:35927270
- 17. Silva A, Cristofori-Armstrong B, Rash LD, Hodgson WC, Isbister GK. Defining the role of post-synaptic α-neurotoxins in paralysis due to snake envenoming in humans. Cell Mol Life Sci. 2018;75(23):4465–78. pmid:30069700
- 18. Tan KY, Tan CH, Fung SY, Tan NH. Neutralization of the principal toxins from the venoms of Thai Naja kaouthia and Malaysian hydrophis schistosus: insights into toxin-specific neutralization by two different antivenoms. Toxins (Basel). 2016;8(4):86. pmid:27023606
- 19. Tan NH, Wong KY, Tan CH. Venomics of Naja sputatrix, the Javan spitting cobra: a short neurotoxin-driven venom needing improved antivenom neutralization. J Proteomics. 2017;157:18–32. pmid:28159706
- 20. Chan YW, Tan CH, Heh CH, Tan KY. An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms. Front Pharmacol. 2023;14:1143437. pmid:37153801
- 21. Tan CH, Tan KY, Wong KY, Tan NH, Chong HP. Equatorial Spitting Cobra (Naja sumatrana) from Malaysia (Negeri Sembilan and Penang), Southern Thailand, and Sumatra: comparative venom proteomics, immunoreactivity and cross-neutralization by antivenom. Toxins (Basel). 2022;14(8):522. pmid:36006183
- 22. Tan CH, Palasuberniam P, Blanco FB, Tan KY. Immunoreactivity and neutralization capacity of Philippine cobra antivenom against Naja philippinensis and Naja samarensis venoms. Trans R Soc Trop Med Hyg. 2021;115(1):78–84. pmid:32945886
- 23. Shan L-L, Gao J-F, Zhang Y-X, Shen S-S, He Y, Wang J, et al. Proteomic characterization and comparison of venoms from two elapid snakes (Bungarus multicinctus and Naja atra) from China. J Proteomics. 2016;138:83–94. pmid:26924299
- 24.
Wong KY. Proteomics and toxinological study of the venoms from Afro-Asian cobras (Naja spp.). Kuala Lumpur, Malaysia: University Malaya; 2019.
- 25. Tan CH, Tan KY, Ng TS, Sim SM, Tan NH. Venom proteome of spine-bellied sea snake (Hydrophis curtus) from Penang, Malaysia: toxicity correlation, immunoprofiling and cross-neutralization by sea snake antivenom. Toxins (Basel). 2018;11(1):3. pmid:30583590
- 26. Tan CH, Wong KY, Tan KY, Tan NH. Venom proteome of the yellow-lipped sea krait, Laticauda colubrina from Bali: insights into subvenomic diversity, venom antigenicity and cross-neutralization by antivenom. J Proteomics. 2017;166:48–58. pmid:28688916
- 27.
Lau DF. Toxinological characterization of long neurotoxin from Malaysian king cobra (Ophiophagus hannah) venom. Universiti Malaya; 2019.
- 28. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25(9):1189–91. pmid:19151095
- 29. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004;5:113. pmid:15318951
- 30. Chong HP, Tan KY, Tan NH, Tan CH. Exploring the diversity and novelty of toxin genes in naja sumatrana, the equatorial spitting cobra from malaysia through de novo venom-gland transcriptomics. Toxins (Basel). 2019;11(2):104. pmid:30754700
- 31. Tan CH, Tan KY. De novo venom-gland transcriptomics of spine-bellied sea snake (Hydrophis curtus) from Penang, Malaysia-next-generation sequencing, functional annotation and toxinological correlation. Toxins (Basel). 2021;13(2):127. pmid:33572266
- 32. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, et al. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 2008;36(Web Server issue):W465-9. pmid:18424797
- 33. de la Rosa G, Corrales-García LL, Rodriguez-Ruiz X, López-Vera E, Corzo G. Short-chain consensus alpha-neurotoxin: a synthetic 60-mer peptide with generic traits and enhanced immunogenic properties. Amino Acids. 2018;50(7):885–95. pmid:29626299
- 34. Barber CM, Isbister GK, Hodgson WC. Alpha neurotoxins. Toxicon. 2013;66:47–58. pmid:23416229
- 35. Leong PK, Fung SY, Tan CH, Sim SM, Tan NH. Immunological cross-reactivity and neutralization of the principal toxins of Naja sumatrana and related cobra venoms by a Thai polyvalent antivenom (Neuro Polyvalent Snake Antivenom). Acta Trop. 2015;149:86–93. pmid:26026717
- 36. Palasuberniam P, Chan YW, Tan KY, Tan CH. Snake venom proteomics of samar cobra (Naja samarensis) from the Southern Philippines: short alpha-neurotoxins as the dominant lethal component weakly cross-neutralized by the philippine cobra antivenom. Front Pharmacol. 2021;12:727756. pmid:35002690
- 37. Tan CH, Wong KY, Chong HP, Tan NH, Tan KY. Proteomic insights into short neurotoxin-driven, highly neurotoxic venom of Philippine cobra (Naja philippinensis) and toxicity correlation of cobra envenomation in Asia. J Proteomics. 2019;206:103418. pmid:31201947
- 38. Yap MKK, Fung SY, Tan KY, Tan NH. Proteomic characterization of venom of the medically important Southeast Asian Naja sumatrana (Equatorial spitting cobra). Acta Trop. 2014;133:15–25. pmid:24508616
- 39. Wong KY, Tan KY, Tan NH, Gnanathasan CA, Tan CH. Elucidating the venom diversity in Sri Lankan Spectacled Cobra (Naja naja) through de novo venom gland transcriptomics, venom proteomics and toxicity neutralization. Toxins (Basel). 2021;13(8):558. pmid:34437429
- 40. Tan KY, Tan CH, Fung SY, Tan NH. Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia. J Proteomics. 2015;120:105–25. pmid:25748141
- 41. Asad MHHB, McCleary RJR, Salafutdinov I, Alam F, Shah HS, Bibi S, et al. Proteomics study of Southern Punjab Pakistani cobra (Naja naja: formerly Naja naja karachiensis) venom. Toxicol Environ Chem. 2019;101(1–2):91–116.
- 42. Lauridsen LP, Laustsen AH, Lomonte B, Gutiérrez JM. Exploring the venom of the forest cobra snake: toxicovenomics and antivenom profiling of Naja melanoleuca. J Proteomics. 2017;150:98–108. pmid:27593527
- 43. Petras D, Sanz L, Segura A, Herrera M, Villalta M, Solano D, et al. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches. J Proteome Res. 2011;10(3):1266–80. pmid:21171584
- 44. Wong KY, Tan KY, Tan NH, Tan CH. A neurotoxic snake venom without phospholipase A2: proteomics and cross-neutralization of the venom from senegalese Cobra, Naja senegalensis (Subgenus: Uraeus). Toxins (Basel). 2021;13(1):60. pmid:33466660
- 45. Tan CH, Wong KY, Huang L-K, Tan KY, Tan NH, Wu W-G. Snake Venomics and Antivenomics of Cape Cobra (Naja nivea) from South Africa: Insights into Venom Toxicity and Cross-Neutralization Activity. Toxins. 2022;14(12):860. https://doi.org/10.3390/toxins14120860
- 46. Tan KY, Wong KY, Tan NH, Tan CH. Quantitative proteomics of Naja annulifera (sub-Saharan snouted cobra) venom and neutralization activities of two antivenoms in Africa. Int J Biol Macromol. 2020;:S0141-8130(20)33035-X. pmid:32339578
- 47. Lin H-C, Li S-H, Fong J, Lin S-M. Ventral coloration differentiation and mitochondrial sequences of the Chinese Cobra (Naja atra) in Taiwan. Conserv Genet. 2007;9(5):1089–97.
- 48.
Sivaganabalan R, Ismail AK, Salleh MS, Mohan K, H TC, Adnan A. Guideline: management of snakebite. First ed. Putrajaya, Malaysia: Ministry of Health Malaysia; 2017.
- 49. Tan CH, Tan KY, Fung SY, Tan NH. Venom-gland transcriptome and venom proteome of the Malaysian king cobra (Ophiophagus hannah). BMC Genomics. 2015;16(1):687. pmid:26358635
- 50. Tan CH, Liew JL, Tan KY, Tan NH. Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study. Sci Rep. 2016;6:37299. pmid:27869134
- 51. Tsetlin VI, Kasheverov IE, Utkin YN. Three-finger proteins from snakes and humans acting on nicotinic receptors: Old and new. J Neurochem. 2021;158(6):1223–35. pmid:32648941
- 52. Fry BG, Wüster W, Kini RM, Brusic V, Khan A, Venkataraman D, et al. Molecular evolution and phylogeny of elapid snake venom three-finger toxins. J Mol Evol. 2003;57(1):110–29. pmid:12962311
- 53. Vázquez Torres S, Benard Valle M, Mackessy SP, Menzies SK, Casewell NR, Ahmadi S, et al. De novo designed proteins neutralize lethal snake venom toxins. Nature. 2025;639(8053):225–31. pmid:39814879
- 54. Puzari U, Fernandes PA, Mukherjee AK. Advances in the therapeutic application of small-molecule inhibitors and repurposed drugs against snakebite. J Med Chem. 2021;64(19):13938–79. pmid:34565143